Inventor · disambiguated record
James L. Riley
Also filed as: RILEY JAMES · RILEY JAMES L · RILEY JAMES W
28 granted patents·24 pending applications·746 citations·filing 1997–2025
97Inventor score
Top patents by PatentIndex Score
52 records- 0197US7754482B2Artificial antigen presenting cells and uses thereforUNIV PENNSYLVANIA·Filed 2005·Granted Jul 13, 2010·109 cites·2 claims
- 0296US8637307B2Activation and expansion of T-cells using an engineered multivalent signaling platform as a research toolJUNE CARL H·Filed 2010·Granted Jan 28, 2014·143 cites·4 claims
- 0395US8722400B2Artificial antigen presenting cells and uses thereforRILEY JAMES L·Filed 2010·Granted May 13, 2014·87 cites·4 claims
- 0495US7745140B2Activation and expansion of T-cells using an engineered multivalent signaling platform as a research toolUNIV PENNSYLVANIA·Filed 2003·Granted Jun 29, 2010·85 cites·26 claims
- 0593US7638326B2Activation and expansion of T-cells using an engineered multivalent signaling platformUNIV PENNSYLVANIA·Filed 2003·Granted Dec 29, 2009·68 cites·15 claims
- 0692US9555105B2Artificial antigen presenting cells and uses thereofUNIV PENNSYLVANIA·Filed 2014·Granted Jan 31, 2017·18 cites·9 claims
- 0791US9133436B2ICOS critically regulates the expansion and function of inflammatory human Th17 cellsRILEY JAMES L·Filed 2011·Granted Sep 15, 2015·16 cites·30 claims
- 0890US7638325B2Activation and expansion of T-cells using an engineered multivalent signaling platformUNIV PENNSYLVANIA·Filed 2003·Granted Dec 29, 2009·35 cites·12 claims
- 0988US10286066B2Artificial antigen presenting cells and uses thereofUNIV PENNSYLVANIA·Filed 2016·Granted May 14, 2019·3 cites·10 claims
- 1084US10874727B2Inducible regulatory t-cell generation for hematopoietic transplantsUNIV PENNSYLVANIA·Filed 2018·Granted Dec 29, 2020·1 cites·11 claims
- 1184US10808225B2Use of PDL1 expressing cells to convert T cells into regulatory T cellsUNIV PENNSYLVANIA·Filed 2017·Granted Oct 20, 2020·2 cites·17 claims
- 1284US8129185B2Regulatory T cells and their use in immunotherapy and suppression of autoimmune responsesBLAZAR BRUCE·Filed 2009·Granted Mar 6, 2012·3 cites·2 claims
- 1384US7651855B2Regulatory T cells and their use in immunotherapy and suppression of autoimmune responsesUNIV PENNSYLVANIA·Filed 2004·Granted Jan 26, 2010·11 cites·14 claims
- 1482US10738099B2Method of redirecting T cells to treat HIV infectionUNIV PENNSYLVANIA·Filed 2016·Granted Aug 11, 2020·2 cites·27 claims
- 1582US7670781B2Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signalUNIV PENNSYLVANIA·Filed 2003·Granted Mar 2, 2010·11 cites·15 claims
- 1681US2024182854A1Methods to Expand a T Regulatory Cell Master Cell BankUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1780US9994818B2ICOS critically regulates the expansion and function of inflammatory human Th17 cellsUNIV PENNSYLVANIA·Filed 2015·Granted Jun 12, 2018·2 cites·5 claims
- 1880US9228172B2Inducible regulatory T-cell generation for hematopoietic transplantsRILEY JAMES L·Filed 2009·Granted Jan 5, 2016·2 cites·13 claims
- 1980US9181526B2Regulatory T cells and their use in immunotherapy and suppression of autoimmune responsesBLAZAR BRUCE·Filed 2012·Granted Nov 10, 2015·2 cites·14 claims
- 2079US2025288655A1Inducible regulatory t-cell generation for hematopoietic transplantsUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 2179US2023399615A1Icos critically regulates the expansion and function of inflammatory human th17 cellsUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2279US2025283040A1Methods to Expand a T Regulatory Cell Master Cell BankUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 2379US2025084147A1Method of Redirecting T Cells to Treat HIV InfectionUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2478US9644179B2Use of PDL1 expressing cells to convert T cells into regulatory T cellsUNIV PENNSYLVANIA·Filed 2012·Granted May 9, 2017·4 cites·6 claims
- 2577US9453199B2Activation and expansion of T-cells using an engineered multivalent signaling platform as a research toolUNIV PENNSYLVANIA·Filed 2013·Granted Sep 27, 2016·1 cites·2 claims
- 2676US11827705B2Methods to protect transplanted tissue from rejectionUNIV PENNSYLVANIA·Filed 2018·Granted Nov 28, 2023·1 cites·13 claims
- 2771US11001805B2ICOS critically regulates the expansion and function of inflammatory human Th17 cellsUNIV PENNSYLVANIA·Filed 2018·Granted May 11, 2021·0 cites·4 claims
- 2871US2020263131A1Methods to Expand a T Regulatory Cell Master Cell BankUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 2971US2021275650A1Inducible regulatory t-cell generation for hematopoietic transplantsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 3068US12122820B2Method of redirecting t cells to treat HIV infectionUNIV PENNSYLVANIA·Filed 2020·Granted Oct 22, 2024·0 cites·11 claims
- 3167US2024158506A1Methods to protect transplanted tissue from rejectionRILEY JAMES L·Filed 2023·Application pending·0 cites
- 3264US6186977B1Apparatus and method for total intravenous anesthesia delivery and associated patient monitoringJOSEPH L RILEY ANESTHESIA ASSO·Filed 1997·Granted Feb 13, 2001·136 cites·45 claims
- 3364US2025152710A1Modified primary immune cells for induction or enhancement of immunotherapyRILEY JAMES L·Filed 2023·Application pending·0 cites
- 3463US2019177692A1Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research ToolUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 3562US9255279B2Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cellsUNIV PENNSYLVANIA·Filed 2014·Granted Feb 9, 2016·0 cites·3 claims
- 3662US2021277356A1Use of pdl1 expressing cells to convert t cells into regulatory t cellsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 3761US2016348072A1Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research ToolUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 3860US2013101567A1Methods to Expand a T Regulatory Cell Master Cell BankRILEY JAMES L·Filed 2011·Application pending·0 cites
- 3958US2023323394A1Improved generation of lentiviral vectors for t cell transduction using cocal envelopeUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 4054US12497623B2Non-signaling HIV fusion inhibitors and methods of use thereofUNIV PENNSYLVANIA·Filed 2021·Granted Dec 16, 2025·0 cites·12 claims
- 4154US2016151471A1Inducible regulatory t-cell generation for hematopoietic transplantsUNIV MINNESOTA·Filed 2015·Application pending·0 cites
- 4253US2020384029A1Dual car expressing t cells individually linked to cd28 and 4-1bbUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 4353US2024226297A9Targeting t regulatory cells to islet cells to stall or reverse type 1 diabetesUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4451US2006204500A1Methods for modulating expression of an HIV-1 fusion cofactorJUNE CARL H·Filed 2006·Application pending·0 cites
- 4550US2025257337A1Augmenting car t cell activityUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 4649US2023000916A1Anti-cd3 scfv and cytokine producing artificial antigen presenting cellsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 4749US2016194616A1Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human CellsUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 4849US2022088071A1A BW6 Specific CAR Designed To Protect Transplanted Tissue From RejectionUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 4948US11597911B2Expansion of populations of T cells by the use of modified serum free mediaLIFE TECHNOLOGIES CORP·Filed 2018·Granted Mar 7, 2023·0 cites·12 claims
- 5047US7927595B1Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodiesUS NAVY·Filed 1998·Granted Apr 19, 2011·4 cites·11 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →